NovaPoint Capital’s iShares iBonds Dec 2026 Term Corporate ETF IBDR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.4M Sell
634,876
-16,771
-3% -$406K 3.86% 1
2025
Q4
$15.8M Buy
651,647
+558,562
+600% +$13.5M 4.07% 2
2025
Q3
$2.26M Buy
93,085
+37,896
+69% +$918K 0.55% 55
2025
Q2
$1.34M Buy
55,189
+20,633
+60% +$498K 0.41% 59
2025
Q1
$837K Buy
+34,556
New +$834K 0.26% 76
2024
Q2
Sell
-31,820
Closed -$759K 138
2024
Q1
$759K Sell
31,820
-4,056
-11% -$96.7K 0.27% 72
2023
Q4
$857K Buy
35,876
+1,149
+3% +$27K 0.32% 68
2023
Q3
$810K Sell
34,727
-7,088
-17% -$166K 0.32% 73
2023
Q2
$981K Buy
41,815
+139
+0.3% +$3.28K 0.37% 69
2023
Q1
$989K Buy
41,676
+509
+1% +$12K 0.41% 64
2022
Q4
$961K Sell
41,167
-40,236
-49% -$934K 0.42% 58
2022
Q3
$1.88M Buy
81,403
+17,006
+26% +$405K 0.85% 49
2022
Q2
$1.53M Sell
64,397
-25,059
-28% -$602K 0.67% 54
2022
Q1
$2.21M Sell
89,456
-1,203
-1% -$30.4K 0.8% 50
2021
Q4
$2.36M Buy
90,659
+11,556
+15% +$303K 0.85% 49
2021
Q3
$2.1M Buy
79,103
+13,419
+20% +$357K 0.84% 50
2021
Q2
$1.75M Buy
65,684
+8,638
+15% +$229K 0.72% 55
2021
Q1
$1.5M Buy
57,046
+17,964
+46% +$480K 0.7% 54
2020
Q4
$1.06M Buy
39,082
+12,005
+44% +$323K 0.55% 56
2020
Q3
$726K Buy
+27,077
New +$727K 0.47% 55

Other funds holding IBDR

NovaPoint Capital's IBDR Position: Q1 2026 in Review

NovaPoint Capital reduced its iShares iBonds Dec 2026 Term Corporate ETF (IBDR) stake by 2.6% in Q1 2026, selling an estimated $406K and leaving 634,876 shares worth $15.4M. The position accounts for 3.86% of the portfolio, ranked #1.

NovaPoint Capital first reported a position in IBDR in Q3 2020 and has held it in 20 quarters since. The position peaked at $15.8M in Q4 2025. 439 funds tracked by Wall St. Rank hold IBDR as of Q1 2026.

  • NovaPoint Capital held 634,876 shares of iShares iBonds Dec 2026 Term Corporate ETF worth $15.4M as of Q1 2026.
  • NovaPoint Capital sold 16,771 iShares iBonds Dec 2026 Term Corporate ETF shares in Q1 2026, an estimated $406K.
  • iShares iBonds Dec 2026 Term Corporate ETF made up 3.86% of NovaPoint Capital's portfolio in Q1 2026, its #1 holding.
  • NovaPoint Capital first reported a position in iShares iBonds Dec 2026 Term Corporate ETF in Q3 2020 and has held it in 20 quarters since.
  • NovaPoint Capital's iShares iBonds Dec 2026 Term Corporate ETF position peaked at $15.8M in Q4 2025.
  • 439 funds tracked by Wall St. Rank held iShares iBonds Dec 2026 Term Corporate ETF as of Q1 2026.

Based on NovaPoint Capital's 13F filing for Q1 2026, filed 6 May 2026.